Hepatitis C Virus-Related Human Hepatocellular Carcinoma: Predictive Markers Using Proteomic Analysis (Methodology)
- 1.7k Downloads
It was reported by El-Serag and Mason (1999) that hepatocellular carcinoma (HCC) is one of the most common fatal cancers world-wide. From the repots by Okuda (1992, 2000) and Seow et al. (2001), the most apparent risk factor for HCC is thought to be the chronic infection with hepatitis B or C virus (HBV or HCV). Although in the other Asian countries HCCs developed from HBV-infection, the characteristic of HCCs in Japan is that they develop from the liver tissues infected with HCV or of liver cirrhosis. From the reports by Yano et al. (2003) and Yatsuhashi (2004), 80% of the death cases of HCC patients have HCV-infection, and the number of HCV-carriers in Japan is 2 million. The number of patients with HCC is still on the increase, although diagnostic and therapeutic techniques have become remarkably advanced. It was reported by Yatsuhashi (2004) that the incidence of HCC is increasing in many developed countries in parallel to an increase in chronic HCV infection. Therefore, it is important to identify the predictive marker proteins by which we can predict the carcinogenesis of HCC in HCV-infected patients.
KeywordsGlutamine Synthetase Protein Spot Ammonium Bicarbonate Noncancerous Tissue Triosephosphate Isomerase
Unable to display preview. Download preview PDF.
- Ha, G.H., Lee, S.U., Kang, D.G., Ha, N.Y., Kim, S.H., Kim, J., Bae, J.M., Kim, J.W., and Lee, C.W. 2002. Proteome analysis of human stomach tissue: separation of soluble proteins by two-dimensional polyacrylamide gel electro-phoresis and identification by mass spectrom-etry. Electrophoresis 23: 2513–2524.PubMedCrossRefGoogle Scholar
- Kuramitsu, Y., Harada, T., Takashima, M., Yokoyama, Y., Hidaka, I., Iizuka, N., Toda, T., Fujimoto, M., Zhang, X., Sakaida, I., Okita, K., Oka, M. and Nakamura, K. 2006. Increased expression, and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues of patients infected with hepatitis C virus. Electrophoresis 27: 1651–1658.PubMedCrossRefGoogle Scholar
- Li, C., Tan, Y-X., Zhou, H. Ding, S.J., Li, S.J., Ma, D.J., Man, X.B., Hong, Y., Zhang, L., Li, L., Xia, Q.C., Wu, J.R,, Wang, H.Y., and Zeng, R. 2005. Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. Proteomics 5: 1125–1139.PubMedCrossRefGoogle Scholar
- Paradis, V., Degos, F., Dargere, D., Pham, N., Belghiti, J., Degott, C., Janeau, J.L., Bezeaud, A., Delforge, D., Cubizolles, M., Laurendeau, I., and Bedossa, P. 2005. Identification of a new marker of hepatocellular carcinoma by serum profiling of patients with chronic liver diseases. Hepatology 41: 40–47.PubMedCrossRefGoogle Scholar
- Takashima, T., Kuramitsu, Y., Yokoyama, Y., Iizuka, N., Toda, T., Saiakida, I., Okita, K., Oka, M., and Nakamura, K. 2003. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 3: 2487–2493.PubMedCrossRefGoogle Scholar
- Takashima, T., Kuramitsu, Y., Yokoyama, Y., Iizuka, N., Fujimoto, M., Nishisaka, T., Sakaida, I., Okita, K., Oka, M., and Nakamura, K. 2005. Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 5: 1686–1692.PubMedCrossRefGoogle Scholar
- Yokoyama, Y., Kuramitsu, Y., Takashima, T., Iizuka, N., Toda, T., Terai, S., Sakaida, I., Oka, M., Nakamura, K., and Okita, K. 2004. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 4: 2111–2116.PubMedCrossRefGoogle Scholar